NCT03958396View on ClinicalTrials.gov

Remifentanil in Children With Obstructive Sleep Apnea

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Remifentanil Infusion

15 minute remifentanil Infusion of either 0.05, 0.1, 0.15 or 0.2 mcg/kg/min

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT03958396 - Remifentanil in Children With Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter